Sermorelin Peptide – User Manual & Dosage Protocol Guide

1

Product Overview

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH 1–29) studied for its ability to stimulate endogenous growth hormone (GH) secretion in research settings.

Research Applications

Growth hormone pulsatility studies
IGF-1 modulation research
Body composition and recovery models
Healthy aging and sleep physiology research

Disclaimer: Sermorelin is for research and experimental use only and is not FDA-approved for therapeutic use in this context.

2

Forms Available

Lyophilized Powder

Storage: Cool, dry environment

Shelf life: Up to 12 months

Reconstituted Solution

Storage: Refrigerated (2–8°C)

Shelf life: 2–4 weeks

Protect From

Light, heat, and contamination

Discard if the solution becomes cloudy or discolored.

3

Mechanism of Action (Research)

Sermorelin is studied for its ability to:

Stimulate the pituitary gland to release endogenous GH
Support pulsatile GH secretion similar to physiologic patterns
Increase downstream IGF-1 signaling
Influence recovery, metabolism, and sleep architecture in experimental models

Effects are primarily observed in preclinical and investigational protocols.

4

Dosage Protocol (Investigational Reference)

There is no approved dosage outside regulated clinical use. The following reflects common research patterns only.

Subcutaneous (SC) Administration

Typical range: 200–500 µg

Frequency: Once daily

Notes: Often scheduled pre-sleep in GH pulse models

Higher-Range Research

Typical range: 500–1000 µg

Frequency: Once daily

Notes: Used in some GH response studies

5

Cycle Framework (Research Models)

Initiation Phase

Duration: 1–2 weeks

Purpose: Response and tolerance evaluation

Active Study Phase

Duration: 8–12 weeks

Purpose: GH/IGF-1 outcome observation

Rest Period

Duration: 2–4 weeks

Purpose: Reset between study cycles

Cycle duration varies by study design and endpoints.

6

Reconstitution Instructions

Supplies

Sterile bacteriostatic water
Sterile syringe
Alcohol swabs

General Procedure

Clean vial stopper with alcohol.
Add bacteriostatic water to desired concentration.

Example: 5 mg vial + 2 mL → 2.5 mg/mL

Swirl gently to dissolve (do not shake).
Refrigerate at 2–8°C after reconstitution.

Use within 2–4 weeks or per protocol.

7

Administration Guidelines (Research Handling)

Subcutaneous Injection Model

Common sites: abdomen, thigh, upper arm
Clean site prior to administration
Inject slowly and rotate sites to minimize irritation

8

Storage Guidelines